๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
To compare, as a preliminary analysis, the effects of MEDI-522 versus place...
Status
Completed
Location
The University of Alabama at Birmingham
Start Date
2003-09
Trial ID
NCT00069017
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-06
Trial ID
NCT00027729
Treatments Being Tested
The primary objective of this study is to compare the effects on disease ac...
Status
Completed
Location
Bressinck, Gibson, Parker, Dinehart, Sanster Dermatology, PA
Start Date
2003-12
Trial ID
NCT00192517
To determine the safety profile of single and multiple doses of MEDI522 in ...
Status
Completed
Location
Institut Gustave Roussy
Start Date
2001-03
Trial ID
NCT00263783
Treatments Being Tested
The primary objectives of this study are: 1. To explore the antitumor acti...
Status
Completed
Location
Clinical Research Consultants, Inc.
Start Date
2003-12
Trial ID
NCT00072930
Treatments Being Tested
RATIONALE: Monoclonal antibodies can locate cancer cells and either kill th...
Status
Completed
Location
University of Wisconsin Comprehensive Cancer Center
Start Date
2002-10
Trial ID
NCT00049712
Treatments Being Tested
\- Assess the safety and tolerance of a weekly MEDI522 regimen in patients ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00284817
To describe the tumor tissue saturation by MEDI-522 in patients with advanc...
Status
Completed
Location
University Of Pittsburgh Cancer Institute
Start Date
2005-05
Trial ID
NCT00111696
Treatments Being Tested
The primary objectives of this study are: * To explore the antitumor activ...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2003-08
Trial ID
NCT00066196
Treatments Being Tested
This phase I/randomized phase II trial is studying the side effects and bes...
Status
Terminated
Location
Fremont - Rideout Cancer Center
Start Date
2008-06
Trial ID
NCT00684996
Treatments Being Tested